// App-Quantinova.ai

6046 : Incidence of ototoxicity in head and neck cancer (HNSCC) patients (pts) receiving concomitant chemo-radiation (CRT) with weekly or triweekly cisplatin (Cis).

Researchers

Presenter

  • Jishu Das

Principal Investigators

  • Amy Custer

  • Dukagjin Blakaj

  • Matthew O. Old

  • Songzhu Zhao

  • Aashish D Bhatt

  • Stephan Y Kang

  • Amit Agrawal

  • Enver Ozer

  • Jessica Wobb

  • Robert Rupert

  • Darrion L Mitchell

  • Guy Brock

  • Claire F. Verschraegen

  • James William Rocco

  • Marcelo R Bonomi

Medical Centers

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Einstein-Montefiore Cancer Ctr, Bronx, NY

  • The Ohio State University - Arthur James Cancer Hospital, Columbus, OH

  • The Ohio State Univerisity, Columbus, OH

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • The James Cancer Hospital and Solove Research Institute, Columbus, OH

  • Ohio State University Wexner Medical Center, Columbus, OH

  • Oakland University William Beaumont School of Medicine, Beaumont Cancer Institute, Royal Oak, MI

  • Ohio State Univ James Care East, Columbus, OH

  • University of Vermont Medical Center, Burlington, VT

  • MEEI/MGH, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved